threonyl-lysyl-proline has been researched along with bromodeoxyuridine in 1 studies
Studies (threonyl-lysyl-proline) | Trials (threonyl-lysyl-proline) | Recent Studies (post-2010) (threonyl-lysyl-proline) | Studies (bromodeoxyuridine) | Trials (bromodeoxyuridine) | Recent Studies (post-2010) (bromodeoxyuridine) |
---|---|---|---|---|---|
7 | 0 | 2 | 13,164 | 71 | 1,816 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Emmetsberger, J; Tsirka, SE | 1 |
1 other study(ies) available for threonyl-lysyl-proline and bromodeoxyuridine
Article | Year |
---|---|
Microglial inhibitory factor (MIF/TKP) mitigates secondary damage following spinal cord injury.
Topics: Animals; Animals, Newborn; Antigens; Autophagy-Related Proteins; Axons; Bromodeoxyuridine; Calcium-Binding Proteins; Cell Proliferation; Cells, Cultured; Cholera Toxin; Chondroitin Sulfate Proteoglycans; Coculture Techniques; Cytokines; Disease Models, Animal; Drug Administration Schedule; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Ki-67 Antigen; Lipopolysaccharides; Macrophage Activation; Mice; Mice, Inbred C57BL; Microfilament Proteins; Microglia; Microscopy, Electron, Transmission; Myelin Basic Protein; Neuroprotective Agents; Oligodendroglia; Oligopeptides; Peptide Fragments; Proteoglycans; Spinal Cord Injuries; Time Factors | 2012 |